Literature DB >> 25063584

Female gender doubles executive dysfunction risk in ALS: a case-control study in 165 patients.

Arianna Palmieri1, Giovanni Mento2, Vincenzo Calvo3, Giorgia Querin4, Carla D'Ascenzo4, Chiara Volpato5, Johann Roland Kleinbub3, Patrizia Silvia Bisiacchi2, Gianni Sorarù5.   

Abstract

BACKGROUND: Cognitive impairment, mainly characterised by executive dysfunction, occurs in about half of cases in amyotrophic lateral sclerosis (ALS). There is evidence that gender influences some clinical features of the disease, but its influence on the cognitive spectrum is unknown. Our objective was to investigate the impact of gender on cognitive profiles of patients with ALS.
METHODS: A retrospective study based on an exhaustive neuropsychological battery was performed in a group of 165 (70 females, 95 males) sporadic, non-demented patients with ALS compared with 134 healthy control participants. This assessment primarily focused on executive, memory and language functions.
RESULTS: 47 (29%) patients revealed impairment in executive function and 30 (18%) patients revealed cognitive non-executive impairment. Independent from mood tone and clinical variables, a significantly greater executive impairment was determined in female patients than in male patients and control participants. The relative risk for ALS females having impairment in executive function compared with male patients was 2.6 (95% CI 1.6 to 4.4; p=0.0003). ALS females scored lower in Phonemic Fluency, Trial Making, and Wisconsin Card Sorting test.
CONCLUSIONS: Results highlight a significant vulnerability of ALS female patients to develop cognitive dysfunctions peculiar to the disease, independently of bulbar onset. The explicative hypotheses of the data are focused on two interpretative lines not mutually exclusive: the role of gonadal hormones and gender-related brain asymmetry pre-existing to the disease. These findings, never reported before in the literature, can have important implications for models of ALS pathogenesis and for future clinical trial designs. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  ALS; Neuropsychology

Mesh:

Year:  2014        PMID: 25063584     DOI: 10.1136/jnnp-2014-307654

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study.

Authors:  Jürgen Keller; Martin Gorges; Hannah T Horn; Helena E A Aho-Özhan; Elmar H Pinkhardt; Ingo Uttner; Jan Kassubek; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

2.  Theory of mind, empathy and neuropsychological functioning in X-linked spinal and bulbar muscular atrophy: a controlled study of 20 patients.

Authors:  Elisa Di Rosa; Gianni Sorarù; Johann Roland Kleinbub; Vincenzo Calvo; Antonino Vallesi; Giorgia Querin; Sonia Marcato; Irene Grasso; Arianna Palmieri
Journal:  J Neurol       Date:  2014-11-20       Impact factor: 4.849

3.  Cognitive impairment across ALS clinical stages in a population-based cohort.

Authors:  Adriano Chiò; Cristina Moglia; Antonio Canosa; Umberto Manera; Rosario Vasta; Maura Brunetti; Marco Barberis; Lucia Corrado; Sandra D'Alfonso; Enrica Bersano; Maria Francesca Sarnelli; Valentina Solara; Jean Pierre Zucchetti; Laura Peotta; Barbara Iazzolino; Letizia Mazzini; Gabriele Mora; Andrea Calvo
Journal:  Neurology       Date:  2019-08-13       Impact factor: 9.910

4.  ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability.

Authors:  Lucio Tremolizzo; Andrea Lizio; Gabriella Santangelo; Susanna Diamanti; Christian Lunetta; Francesca Gerardi; Sonia Messina; Stefania La Foresta; Nilo Riva; Yuri Falzone; Massimo Filippi; Susan C Woolley; Valeria Ada Sansone; Mattia Siciliano; Carlo Ferrarese; Ildebrando Appollonio
Journal:  Neurol Sci       Date:  2019-12-05       Impact factor: 3.307

Review 5.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

6.  Action processing and mirror neuron function in patients with amyotrophic lateral sclerosis: an fMRI study.

Authors:  Laura Jelsone-Swain; Carol Persad; David Burkard; Robert C Welsh
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

7.  Hypnosis-based psychodynamic treatment in ALS: a longitudinal study on patients and their caregivers.

Authors:  Johann R Kleinbub; Arianna Palmieri; Alice Broggio; Francesco Pagnini; Enrico Benelli; Marco Sambin; Gianni Sorarù
Journal:  Front Psychol       Date:  2015-06-16

8.  The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese Amyotrophic Lateral Sclerosis Population.

Authors:  Shan Ye; Ying Ji; Chengyu Li; Ji He; Xiaolu Liu; Dongsheng Fan
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

Review 9.  Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?

Authors:  Francesca Trojsi; Giulia D'Alvano; Simona Bonavita; Gioacchino Tedeschi
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

Review 10.  Sex and Gender Differences in Central Nervous System-Related Disorders.

Authors:  Emanuela Zagni; Lucia Simoni; Delia Colombo
Journal:  Neurosci J       Date:  2016-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.